Chemistry:JM-1232

From HandWiki
Short description: Chemical compound
JM-1232
JM-1232 Structure.svg
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC24H27N3O2
Molar mass389.499 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

JM-1232 is a sedative and hypnotic drug being researched as a potential anesthetic. It has similar effects to sedative-hypnotic benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine hypnotic.[1][2][3][4][5][6] It was developed by a team at Maruishi Pharmaceutica.[7]

A human study explored the sedation caused by infusions at a range of doses, finding a fair hemodynamic safety profile.[8]

References

  1. "Novel water-soluble sedative-hypnotic agents: isoindolin-1-one derivatives". Chemical & Pharmaceutical Bulletin 55 (12): 1682–1688. December 2007. doi:10.1248/cpb.55.1682. PMID 18057740. 
  2. "Antinociceptive property of intrathecal and intraperitoneal administration of a novel water-soluble isoindolin-1-one derivative, JM 1232 (-) in rats". European Journal of Pharmacology 596 (1–3): 56–61. October 2008. doi:10.1016/j.ejphar.2008.07.054. PMID 18708047. 
  3. "The antinociceptive effects and pharmacological properties of JM-1232(-): a novel isoindoline derivative". Anesthesia and Analgesia 108 (3): 1008–1014. March 2009. doi:10.1213/ane.0b013e318193678f. PMID 19224817. 
  4. "The shivering threshold in rabbits with JM-1232(-), a new benzodiazepine receptor agonist". Anesthesia and Analgesia 109 (1): 96–100. July 2009. doi:10.1213/ane.0b013e3181a1a5ed. PMID 19439682. 
  5. "Effect of JM-1232(-), a New Sedative on Central Respiratory Activity in Newborn Rats". New Frontiers in Respiratory Control. Advances in Experimental Medicine and Biology. 669. 2010. pp. 115–118. doi:10.1007/978-1-4419-5692-7_23. ISBN 978-1-4419-5691-0. 
  6. "New drugs and technologies, intravenous anaesthesia is on the move (again)". British Journal of Anaesthesia 105 (3): 246–254. September 2010. doi:10.1093/bja/aeq190. PMID 20650920. 
  7. Toyooka K, Kanamitsu N, Yoshimura M, Kuriyama H, Tamura T, "Isoindoline Derivative", EP patent 1566378, issued 15 August 2012, assigned to Maruishi Pharmaceutical Co Ltd.
  8. "First human administration of MR04A3: a novel water-soluble nonbenzodiazepine sedative". Anesthesiology 116 (2): 385–395. February 2012. doi:10.1097/ALN.0b013e318242b2af. PMID 22222479.